| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 1 security · passive | ||||||
|
Aquestive Therapeutics, Inc.
13G
AQST · 03843E104
|
7.5% |
10/7/2026
Event 10/7/2026
|
||||
| Bass Edward P | 7.5% | |||||
| Thru Line L.P. | 6.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.